Ind-Swift Laboratories Ltd. (INDSWFTLA): Ind-Swift Laboratories Share Price Near 52-Week High as Market Cap Stands at Rs 3,550.64 Cr
- September 24, 2026
- Posted by: Chaitanya Auti
- Category: News
Ind-Swift Laboratories Share Price is Rs 416, up 0.57%, near its 52-week high, with market capitalisation at Rs 3,550.64 Cr.
Ind-Swift Laboratories Share Price is trading at Rs 416, up 0.57% from the previous close of Rs 413.65, and the stock is moving close to its 52-week high with a market capitalisation of Rs 3,550.64 Cr. As of 30 September 2026 at 9:22 AM IST, this Ind-Swift Laboratories Share Price update places the stock within sight of its yearly high after a session that opened at Rs 415 and traded between Rs 415 and Rs 424.55. The move is relevant because it confirms a near 52-week high event, while the latest Univest figures also show a valuation profile that investors may want to read alongside the price action.
For readers tracking Ind-Swift Laboratories Share Price Today, the latest Ind-Swift Laboratories Share News is straightforward: the stock has held above the prior close and stayed near the upper end of the intraday range. In stock market terms, that keeps Ind-Swift Laboratories Share Price in the 52 Week High Stocks category for the day, with no company-specific catalyst established by the latest data. Univest is following the stock closely because the current move comes with visible valuation, earnings and sector metrics already on record.
Ind-Swift Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 416 |
| Previous Close | Rs 413.65 |
| Today's Move | +Rs 2.35 (+0.57%) |
| Open | Rs 415 |
| High | Rs 424.55 |
| Low | Rs 415 |
| Market Capitalisation | Rs 3,550.64 crore |
Ind-Swift Laboratories Ltd. (INDSWFTLA) traded at Rs 416 versus the previous close of Rs 413.65, a rise of 0.57%. The stock opened at Rs 415, reached a high of Rs 424.55 and touched a low of Rs 415.
Ind-Swift Laboratories Share Price Today shows Rs 416 versus the previous close of Rs 413.65, a gain of Rs 2.35 or 0.57%. The day opened at Rs 415, matched the low at Rs 415 and reached Rs 424.55 during the morning session. That leaves the stock trading close to its 52-week high and above the opening print, which makes the price action relevant for anyone scanning Stocks in News, Market Movers and Stock Updates on the Indian Stock Market.
What exactly happened today is simple and factual: Ind-Swift Laboratories Share Price moved higher than the prior close and approached its yearly high area without a fresh company-specific trigger being established by the latest figures. The stock’s position in the day range, combined with the near 52-week high event, is the main reason the move is drawing notice in Univest stock coverage. For readers following Ind-Swift Laboratories Share Price Live, the event is best read as a price update first, not as a confirmed business turnaround story.
This sets up the next question for Ind-Swift Laboratories Share Price Today: whether the current valuation and financial profile support the latest move.
Ind-Swift Laboratories Ltd. (INDSWFTLA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 3,550.64 crore |
| P/E Ratio | 62.75x |
| P/B Ratio | 2.56x |
| ROE | 3.47% |
| ROCE | 4% |
| EPS | Rs 6.59 |
| Book Value Per Share | Rs 161.89 |
| Dividend Yield | 0% |
Ind-Swift Laboratories Ltd. (INDSWFTLA) fundamental metrics show P/E 62.75x, P/B 2.56x, ROE 3.47%, ROCE 4%. These figures provide context only and are not a buy or sell signal.
Ind-Swift Laboratories Ltd. has a market capitalisation of Rs 3550.64 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 62.75x, P/B at 2.56x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 3.47% and ROCE of 4%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 6.59, book value per share of Rs 161.89, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.2x, median ROE of 11.74%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 62.75x |
| Benchmark Median P/E | 28.2x |
| Benchmark Average P/E | 41.9x |
| Benchmark P/E Range | 0x to 699.02x |
| Company P/B Ratio | 2.56x |
| Benchmark Median P/B | 2.89x |
| Company ROE | 3.47% |
| Benchmark Median ROE | 11.74% |
| Company ROCE | 4% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 3,550.64 crore |
| Benchmark Median Market Cap | Rs 773.14 crore |
Ind-Swift Laboratories Ltd. (INDSWFTLA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Ind-Swift Laboratories Ltd. (INDSWFTLA) has a P/E ratio of 62.75x, which is above the benchmark median of 28.2x, a difference of +122.52%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Ind-Swift Laboratories Ltd. (INDSWFTLA) has a ROE of 3.47%, which is below the benchmark median of 11.74%, a difference of -70.44%. Ind-Swift Laboratories Ltd. (INDSWFTLA) has a ROCE of 4%, which is below the benchmark median of 13.63%, a difference of -70.65%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Solara Active Pharma Sciences Ltd. | SOLARA | 3,557.03 | 0 | 2.85 | -0.63 | 4.61 |
| Kwality Pharmaceuticals Ltd. | KPL | 3,714.94 | 46.43 | 10.56 | 22.67 | 24.01 |
| Unichem Laboratories Ltd. | UNICHEMLAB | 3,781.49 | 13.11 | 1.45 | 9.81 | 10.68 |
| Aarti Drugs Ltd. | AARTIDRUGS | 3,915.94 | 20.58 | 2.46 | 13.36 | 12.04 |
| Advanced Enzyme Technologies Ltd. | ADVENZYMES | 3,178.44 | 19.07 | 1.9 | 11.43 | 15.27 |
Ind-Swift Laboratories Ltd. (INDSWFTLA) has a P/E ratio of 62.75x compared with the displayed peer median of 19.07x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 3.47% compares with a peer median of 11.43% across the companies shown in the table. ROCE stood at 4% versus the displayed peer median of 12.04%, providing a capital-efficiency comparison. Ind-Swift Laboratories Ltd. (INDSWFTLA) has a market capitalisation of Rs 3,550.64 crore. Among the 5 peers shown, 4 have a larger market capitalisation.
Why Investors Are Watching Ind-Swift Laboratories
- Ind-Swift Laboratories Share Price is Rs 416, up 0.57% from the previous close.
- Ind-Swift Laboratories Share Price Today is trading close to the 52-week high at Rs 424.55 for the day.
- Ind-Swift Laboratories Share Price carries a market capitalisation of Rs 3,550.64 Cr.
- Ind-Swift Laboratories Fundamental Analysis shows P/E at 62.75, P/B at 2.56, ROE at 3.47% and ROCE at 4%.
- Ind-Swift Laboratories Stock News also includes revenue of Rs 1,914.54 in June 2026 and net profit of Rs 246.84 in June 2026.
About Ind-Swift Laboratories
Ind-Swift Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. That classification is central to any Ind-Swift Laboratories Company News or Ind-Swift Laboratories Latest News update, because it frames how the stock is compared with peers and with the broader sector benchmark. For readers searching Ind-Swift Laboratories Share Price, Univest keeps the focus on verified market data, financial results, and the company’s listed market context rather than unsupported commentary. The stock’s current position near its 52-week high makes that context especially relevant for stock market today screens.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Registration Number INH000013776), a subsidiary of Univest Communication Technologies Private Limited.
Frequently Asked Questions
Why is Ind-Swift Laboratories Share Price in the news today?
What is Ind-Swift Laboratories Share Price Today?
Ans. Ind-Swift Laboratories Share Price Today is Rs 416. The stock was up Rs 2.35 from the previous close of Rs 413.65 and touched an intraday high of Rs 424.55 during the morning session.
How far is Ind-Swift Laboratories Share Price from its 52-week high?
Ans. Ind-Swift Laboratories Share Price is trading near its 52-week high. The latest session high was Rs 424.55, while the current price stood at Rs 416, keeping it close to that yearly peak area.
What does the current valuation of Ind-Swift Laboratories show?
Ans. Ind-Swift Laboratories Share Price has a P/E of 62.75 and a P/B of 2.56. That places it above the industry median P/E and below the industry median P/B in the healthcare benchmark set.
How strong are the profitability ratios for Ind-Swift Laboratories?
Ans. Ind-Swift Laboratories Share Price comes with ROE of 3.47% and ROCE of 4%. Both are below the same-industry benchmark medians, which helps explain the stock’s mixed fundamental profile.
What are the latest earnings and revenue figures for Ind-Swift Laboratories?
Ans. Ind-Swift Laboratories Share Price is supported by June 2026 revenue of Rs 1,914.54 and net profit of Rs 246.84. For June 2025, revenue was Rs 1,583.22 and net profit was Rs 87.74.
How does Ind-Swift Laboratories compare with its peers?
Ans. Ind-Swift Laboratories Share Price sits near peers such as Solara Active Pharma Sciences on market cap. Its P/E is above Unichem Laboratories, Aarti Drugs and Advanced Enzyme Technologies, while ROE and ROCE are below most listed peers.
Can investors track Ind-Swift Laboratories Share Price on Univest?
Ans. Yes. Univest tracks Ind-Swift Laboratories Share Price, 52-week levels, valuation ratios, company financials and sector comparison so readers can monitor the stock in one place. The stock moved 0.57% so far today.
Track Ind-Swift Laboratories Share Price on Univest
Use Ind-Swift Laboratories Ltd. (INDSWFTLA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Ind-Swift Laboratories Share Price on Univest for live price updates, 52-week levels, key valuation ratios, company financials, and sector comparison. Univest also helps readers follow Ind-Swift Laboratories Share Price Today, Ind-Swift Laboratories Stock Analysis and Ind-Swift Laboratories Share Price Live in one place.